Ranexa is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Carilion Materials Management. The primary component is Ranolazine.
Product ID | 68151-5004_892444ae-b9ca-4022-bcd3-f676848f83e8 |
NDC | 68151-5004 |
Product Type | Human Prescription Drug |
Proprietary Name | Ranexa |
Generic Name | Ranolazine |
Dosage Form | Tablet, Film Coated, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2006-01-27 |
Marketing Category | NDA / NDA |
Application Number | NDA021526 |
Labeler Name | Carilion Materials Management |
Substance Name | RANOLAZINE |
Active Ingredient Strength | 500 mg/1 |
Pharm Classes | Anti-anginal [EPC],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 2006-01-27 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021526 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2006-01-27 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
RANOLAZINE | 500 mg/1 |
SPL SET ID: | e038f963-d78f-460e-a11f-46f224061505 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
43353-880 | Ranexa | RANOLAZINE |
68151-5004 | Ranexa | Ranexa |
61958-1003 | Ranexa | Ranexa |
61958-1001 | Ranexa | Ranexa |
61958-1004 | Ranexa | Ranexa |
61958-1002 | Ranexa | Ranexa |
47335-624 | ASPRUZYO SPRINKLE | Ranolazine |
47335-625 | ASPRUZYO SPRINKLE | Ranolazine |
27241-125 | Ranolazine | Ranolazine |
27241-126 | Ranolazine | Ranolazine |
31722-668 | Ranolazine | Ranolazine |
31722-669 | Ranolazine | Ranolazine |
42291-773 | Ranolazine | RANOLAZINE |
42291-774 | Ranolazine | RANOLAZINE |
42385-963 | Ranolazine | Ranolazine |
42385-964 | Ranolazine | Ranolazine |
42571-324 | Ranolazine | Ranolazine |
42571-325 | Ranolazine | Ranolazine |
43975-289 | Ranolazine | Ranolazine |
43975-290 | Ranolazine | Ranolazine |
45963-418 | Ranolazine | Ranolazine |
45963-419 | Ranolazine | Ranolazine |
48792-7893 | RANOLAZINE | ranolazine |
48792-7894 | RANOLAZINE | ranolazine |
50228-423 | RANOLAZINE | RANOLAZINE |
50228-424 | RANOLAZINE | RANOLAZINE |
50268-722 | Ranolazine | Ranolazine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
RANEXA 86723196 5163874 Live/Registered |
Gilead Sciences, Inc. 2015-08-12 |
RANEXA 78397268 3094007 Live/Registered |
GILEAD SCIENCES, INC. 2004-04-06 |
RANEXA 78051432 not registered Dead/Abandoned |
CV Therapeutics, Inc. 2001-03-05 |
RANEXA 77489909 3944703 Live/Registered |
GILEAD SCIENCES, INC. 2008-06-03 |
RANEXA 77112751 not registered Dead/Abandoned |
GILEAD PALO ALTO, INC. 2007-02-21 |
RANEXA 76978127 3117797 Dead/Cancelled |
GILEAD SCIENCES, INC. 2003-11-19 |
RANEXA 76560883 not registered Dead/Abandoned |
CV Therapeutics 2003-11-19 |